Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures

NCT03059381 · clinicaltrials.gov ↗

COMPLETED

Status

519

Enrollment

INDUSTRY

Sponsor class

Conditions

Partial Seizures (With or Without Secondary Generalized Seizures)
Primary Generalized Tonic-clonic Seizures

Interventions

DRUG: Fycompa

Sponsor

Eisai Co., Ltd.